Table 2. Clinical Features of NAFLD and CHB Patients, and Univariate Comparison of Clinical and Histological Features of Patients.
| NAFLD patients | CHB patients | P value | |
|---|---|---|---|
| Number | 52 | 68 | |
| Age | 48 | 39.5 | 0.102 |
| Gender (Female) | 21 (40.4%) | 22 (32.4%) | 0.365 |
| BMI (kg/m2) | 27.7 | 22.8 | < 0.001 |
| Obesity (BMI > 25) | 39 (75.0%) | 21 (30.9%) | < 0.001 |
| Diabetes | 24 (46.2%) | 5 (7.4%) | < 0.001 |
| Hyperlipidemia | 35 (67.3%) | 22 (32.4%) | < 0.001 |
| Hypertension | 32 (61.5%) | 22 (32.4%) | 0.002 |
| AST (U/L) | 63 | 49.5 | 0.319 |
| ALT (U/L) | 92.5 | 78.5 | 0.136 |
| Total bilirubin (mg/dL) | 0.6 | 0.7 | 0.134 |
| Albumin (g/dL) | 4.2 | 4 | < 0.001 |
| Triglycerides (mg/dL) | 151 | 95 | < 0.001 |
| Total cholesterol (mg/dL) | 207 | 177 | < 0.001 |
| Glucose (mg/dL) | 101 | 89 | < 0.001 |
| Platelet count (104/µL) | 19.8 | 16.1 | 0.004 |
| Prothrombin time (%) | 100 | 95.5 | 0.115 |
| Appendectomy | 19 (36.5%) | 12 (17.6%) | 0.020 |
| Steatosis (grade 0/1/2/3) | 0/23/17/12 | 37/21/9/1 | 0.001 |